Expression of granulocyte colony-stimulating factor receptor in rectal cancer

Table 1 Relationship between granulocyte colony-stimulating factor receptor expression and clinicopathological factors

Clinicopathological	Cases	G-CSFR				Pvalue	r
parameters		0	1	2	3
		41	26	28	31
Age (yr)
< 60	67	20	17	15	15
≥ 60	59	21	9	13	16	NS
Gender
Male	54	18	10	11	15
Female	72	23	16	17	16	NS
Pathological stage
LN-	72	21	12	20	19
LN+	54	20	14	8	12	NS
T3	38	13	6	9	10
T4	88	28	20	19	21	NS
Size (cm2)
> 15	66	18	14	15	19
≤ 15	60	23	12	13	12	NS
Differentiation
Well	36	15	6	10	5
Moderate	55	17	15	13	10
Poor	35	9	5	5	16	0.019	0.210
Sphincter preservation
Yes	81	32	15	17	17
No	45	9	11	11	14	0.044	0.180
Distance from anal verge (cm)
5-10	82	28	17	19	18
< 5	44	13	9	9	13	NS
Pathological response
Complete	37	18	7	5	7
Partial	44	13	10	11	10
No response	45	10	9	12	14	0.014	0.219

G-CSFR: Granulocyte colony-stimulating factor receptor; NS: Not significant; LN: Lymph nodes.